Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma.
Sun S, Qi W, Rehrauer H, Ronner M, Hariharan A, Wipplinger M, Meiller C, Stahel R, Früh M, Cerciello F, Fonteneau JF, Jean D, Felley-Bosco E. Sun S, et al. Among authors: fonteneau jf. JTO Clin Res Rep. 2022 Nov 7;3(12):100430. doi: 10.1016/j.jtocrr.2022.100430. eCollection 2022 Dec. JTO Clin Res Rep. 2022. PMID: 36467966 Free PMC article.
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
Grard M, Idjellidaine M, Arbabian A, Chatelain C, Berland L, Combredet C, Dutoit S, Deshayes S, Dehame V, Labarrière N, Fradin D, Boisgerault N, Blanquart C, Tangy F, Fonteneau JF. Grard M, et al. Among authors: fonteneau jf. Cancer Immunol Immunother. 2023 Oct;72(10):3309-3322. doi: 10.1007/s00262-023-03486-4. Epub 2023 Jul 19. Cancer Immunol Immunother. 2023. PMID: 37466668 Free PMC article.
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.
Hariharan A, Qi W, Rehrauer H, Wu L, Ronner M, Wipplinger M, Kresoja-Rakic J, Sun S, Oton-Gonzalez L, Sculco M, Serre-Beinier V, Meiller C, Blanquart C, Fonteneau JF, Vrugt B, Rüschoff JH, Opitz I, Jean D, de Perrot M, Felley-Bosco E. Hariharan A, et al. Among authors: fonteneau jf. Mol Oncol. 2022 Dec;16(22):3949-3974. doi: 10.1002/1878-0261.13322. Epub 2022 Oct 31. Mol Oncol. 2022. PMID: 36221913 Free PMC article.
Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways.
Charrier M, Lorant J, Contreras-Lopez R, Téjédor G, Blanquart C, Lieubeau B, Schleder C, Leroux I, Deshayes S, Fonteneau JF, Babarit C, Hamel A, Magot A, Péréon Y, Viau S, Delorme B, Luz-Crawford P, Lamirault G, Djouad F, Rouger K. Charrier M, et al. Among authors: fonteneau jf. Stem Cell Res Ther. 2022 Jan 10;13(1):7. doi: 10.1186/s13287-021-02681-3. Stem Cell Res Ther. 2022. PMID: 35012660 Free PMC article.
[The yellow fever vaccine as a new cancer treatment?].
Petithomme T, Grard M, Fonteneau JF, Boisgerault N. Petithomme T, et al. Among authors: fonteneau jf. Med Sci (Paris). 2020 Dec;36(12):1216-1217. doi: 10.1051/medsci/2020236. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296641 Free article. French. No abstract available.
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma.
Delaunay T, Nader J, Grard M, Farine I, Hedwig V, Foloppe J, Blondy T, Violland M, Pouliquen D, Grégoire M, Boisgerault N, Erbs P, Fonteneau JF. Delaunay T, et al. Among authors: fonteneau jf. Mol Ther Oncolytics. 2020 Aug 25;18:573-578. doi: 10.1016/j.omto.2020.08.011. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32995481 Free PMC article.
73 results